Financial resources, access to care, and quality of care mediate racial disparities in statin usage for secondary prevention
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: There are disparities in statin therapy for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD). The role of structural racism in this disparity has not been examined. METHODS: This is a cross-sectional study of participants with ASCVD in the Medical Expenditure Panel Survey from 2014-2017. Mediation analysis is utilized to estimate the direct effect of race and indirect effect of financial resources, access to care, and quality of care on statin usage. RESULTS: The proportion of participants using statins by race/ethnicity were 58.5% for non-Hispanic Whites, 45% for Hispanics, 48.6% for Blacks, 61.6% for Asians, and 46.8% for Others. Statin usage was lower for Hispanics (OR = 0.79, 95% confidence interval [0.65-0.96]) and Blacks (OR = 0.80 [0.66-0.95]) compared to Whites. Hispanic, Black, and Other participants with the same financial resources, access to care, and quality of care as White participants did not have significantly different statin usage compared to White participants (Hispanic: OR = 0.98 [0.79-1.13]; Black (OR = 0.88 [0.76-1.06], Other: OR 0.76, 95% CI [0.56-1.15]). Hispanic, Black, and Other participants had significantly lower statin usage than subjects of the same race but with financial resources, access to care, and quality of care observed in White subjects (Hispanic: OR = 0.83 [0.83-0.92]; Black: OR = 0.91[0.88-0.94]; Other: OR = 0.92 [0.87-0.98]). DISCUSSION: The indirect effect of race and ethnicity on statin therapy are significant but the direct effect of race and ethnicity on statin therapy are insignificant among Blacks and Hispanics compared to non-Hispanic Whites. This suggests that racial disparities in statin therapy are mediated through inequitably distributed resources, suggestive of the impact of structural racism.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Financial resources, access to care, and quality of care mediate racial disparities in statin usage for secondary prevention
- Date Crossref
- 08/10/2024
- Éditeur
- Public Library of Science (PLoS)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
The State University of New Jersey Rutgers pays non établi dans la noticeUniversité ou école supérieure
-
Johnson University pays non établi dans la noticeUniversité ou école supérieure
-
Donald & Barbara Zucker School of Medicine at Hofstra/Northwell Department of Cardiology pays non établi dans la noticeUniversité ou école supérieure
-
City University of New York pays non établi dans la noticeUniversité ou école supérieure
-
Hofstra University pays non établi dans la noticeUniversité ou école supérieure
-
Lenox Hill Hospital pays non établi dans la noticeÉtablissement de santé
-
Rutgers Robert Wood Johnson School of Medicine Division of Cardiology pays non établi dans la noticeUniversité ou école supérieure
-
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Division of General Internal Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Graduate School of Public Health and Health Policy Department of Epidemiology and Biostatistics pays non établi dans la noticeUniversité ou école supérieure
Rutgers — The State University of New Jersey, Johnson University et Department of Cardiology — Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, avec 6 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.